General form of registration statement for all companies including face-amount certificate companies

Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders??? Deficit

v3.21.2
Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Series C Redeemable Convertible Preferred Stock
Series D Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Series C Redeemable Convertible Preferred Stock
Additional Paid-In Capital
Series D Redeemable Convertible Preferred Stock
Accumulated Deficit
Balance as of beginning of period (in shares) at Dec. 31, 2018 25,602,868              
Balance as of beginning of period at Dec. 31, 2018 $ 91,826              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of redeemable convertible preferred stock and common stock, net of issuance costs (in shares) 3,258,288              
Issuance of redeemable convertible preferred stock and common stock, net of issuance costs $ 11,035              
Conversion of redeemable convertible preferred stock (in shares) (893,260)              
Conversion of redeemable convertible preferred stock $ (1,003)              
Balance as of end of period (in shares) at Dec. 31, 2019 27,967,896 8,688,760            
Balance as of end of period at Dec. 31, 2019 $ 101,858 $ 40,978            
Balance as of beginning of period (in shares) at Dec. 31, 2018       7,792,649        
Balance as of beginning of period at Dec. 31, 2018 (84,756)     $ 1 $ 3,585     $ (88,342)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of redeemable convertible preferred stock and common stock, net of issuance costs (in shares)       9,227,960        
Issuance of Series C redeemable convertible preferred stock and common stock, net of issuance costs 6,809       6,809      
Conversion of redeemable convertible preferred stock (in shares)       893,260        
Conversion of redeemable convertible preferred stock $ 1,003       1,003      
Issuance of common stock upon exercise of stock options (in shares) 151,000     150,826        
Issuance of common stock upon exercise of stock options $ 159       159      
Issuance of warrants   $ 168       $ 168    
Stock-based compensation 1,472       1,472      
Net loss (25,678)             (25,678)
Balance as of end of period (in shares) at Dec. 31, 2019       18,064,695        
Balance as of end of period at Dec. 31, 2019 $ (100,823)     $ 1 13,196     (114,020)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of redeemable convertible preferred stock and common stock, net of issuance costs (in shares) 75,660,962              
Issuance of redeemable convertible preferred stock and common stock, net of issuance costs $ 28,278              
Conversion of redeemable convertible preferred stock (in shares) (4,456,248)              
Conversion of redeemable convertible preferred stock $ (13,274)              
Exchange of convertible notes and accrued interest for Series D redeemable convertible preferred stock (in shares) 4,029,222              
Exchange of convertible notes and accrued interest for Series D redeemable convertible preferred stock $ 1,512              
Balance as of end of period (in shares) at Jun. 30, 2020 103,201,832              
Balance as of end of period at Jun. 30, 2020 $ 118,374              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of redeemable convertible preferred stock (in shares)       1,485,413        
Conversion of redeemable convertible preferred stock $ 13,274       223     13,051
Issuance of common stock upon exercise of stock options (in shares) 50,000     49,848        
Issuance of common stock upon exercise of stock options $ 39       39      
Stock-based compensation 777       777      
Net loss (10,484)             (10,484)
Balance as of end of period (in shares) at Jun. 30, 2020       19,599,956        
Balance as of end of period at Jun. 30, 2020 $ (97,217)     $ 1 14,235     (111,452)
Balance as of beginning of period (in shares) at Dec. 31, 2019 27,967,896 8,688,760            
Balance as of beginning of period at Dec. 31, 2019 $ 101,858 $ 40,978            
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of redeemable convertible preferred stock and common stock, net of issuance costs (in shares) 75,660,962              
Issuance of redeemable convertible preferred stock and common stock, net of issuance costs $ 28,153              
Conversion of redeemable convertible preferred stock (in shares) (4,456,248)              
Conversion of redeemable convertible preferred stock $ (13,274)              
Exchange of convertible notes and accrued interest for Series D redeemable convertible preferred stock (in shares) 18,561,773              
Exchange of convertible notes and accrued interest for Series D redeemable convertible preferred stock $ 6,967              
Balance as of end of period (in shares) at Dec. 31, 2020 117,734,383 8,399,058 94,222,735          
Balance as of end of period at Dec. 31, 2020 $ 123,704 $ 39,378 $ 35,120          
Balance as of beginning of period (in shares) at Dec. 31, 2019       18,064,695        
Balance as of beginning of period at Dec. 31, 2019 (100,823)     $ 1 13,196     (114,020)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of redeemable convertible preferred stock (in shares)       1,485,413        
Conversion of redeemable convertible preferred stock $ 13,274       223     13,051
Issuance of common stock upon exercise of stock options (in shares) 67,000     87,764        
Issuance of common stock upon exercise of stock options $ 53       53      
Issuance of warrants     $ 27       $ 27  
Stock-based compensation 1,455       1,455      
Net loss (21,807)             (21,807)
Balance as of end of period (in shares) at Dec. 31, 2020       19,637,872        
Balance as of end of period at Dec. 31, 2020 $ (107,821)     $ 1 14,954     (122,776)
Balance as of end of period (in shares) at Dec. 31, 2020 117,734,383 8,399,058 94,222,735          
Balance as of end of period at Dec. 31, 2020 $ 123,704 $ 39,378 $ 35,120          
Balance as of end of period (in shares) at Dec. 31, 2020       19,637,872        
Balance as of end of period at Dec. 31, 2020 $ (107,821)     $ 1 14,954     (122,776)
Balance as of beginning of period (in shares) at Dec. 31, 2020 117,734,383 8,399,058 94,222,735          
Balance as of beginning of period at Dec. 31, 2020 $ 123,704 $ 39,378 $ 35,120          
Balance as of end of period (in shares) at Jun. 30, 2021 117,734,383 8,399,058 94,222,735          
Balance as of end of period at Jun. 30, 2021 $ 123,704 $ 39,378 $ 35,120          
Balance as of beginning of period (in shares) at Dec. 31, 2020       19,637,872        
Balance as of beginning of period at Dec. 31, 2020 $ (107,821)     $ 1 14,954     (122,776)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares) 203,000     202,500        
Issuance of common stock upon exercise of stock options $ 283       283      
Issuance of warrants 134       134      
Stock-based compensation 1,075       1,075      
Net loss (26,086)             (26,086)
Balance as of end of period (in shares) at Jun. 30, 2021       19,840,372        
Balance as of end of period at Jun. 30, 2021 $ (132,414)     $ 1 16,446     (148,861)
Balance as of end of period (in shares) at Jun. 30, 2021 117,734,383 8,399,058 94,222,735          
Balance as of end of period at Jun. 30, 2021 $ 123,704 $ 39,378 $ 35,120          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (13,548)              
Balance as of end of period (in shares) at Jun. 30, 2021       19,840,372        
Balance as of end of period at Jun. 30, 2021 $ (132,414)     $ 1 $ 16,446     $ (148,861)